Reimagining drugs for a rare brain disorder

A team of researchers has developed a new method to screen FDA-approved drugs to determine if they could be repurposed or improved to help patients with a rare, debilitating disease of the nervous system.

Team achieves breakthrough using CRISPR-Cas9 to target fat cells

Fat—it is tvital for life but too much can lead to a host of health problems. Studying how fat—or adipose—tissue functions in the body is critical for understanding obesity and other issues, yet structural differences ...

New insights into cell polarity

A previously unknown mechanism involving the protein Scribble helps maintain polarity in cells, according to a Northwestern Medicine study published in the Journal of Biological Chemistry.

New process yields more, purer RNA at a fraction of the cost

Researchers at the University of Massachusetts Amherst recently unveiled their discovery of a new process for making RNA. The resulting RNA is purer, more copious and likely to be more cost-effective than any previous process ...

page 2 from 32